Novel transformative solutions require risk. We need to increase the incentives to take such risk. Using platelet rich plasma for sports related injuries a decade ago was crazy. Now it is commonplace and backed up with level one data for chronic problems such as tennis elbow.
How can we encourage providers and payers to take more risks to help patients?